These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24352737)

  • 1. Drug-coated balloons in the treatment of small vessel disease.
    Rittger H; Scheller B
    Heart; 2014 Feb; 100(4):274-5. PubMed ID: 24352737
    [No Abstract]   [Full Text] [Related]  

  • 2. New technologies in percutaneous coronary interventions: drug-coated balloons.
    Kleber FX; Scheller B; Serruys PW
    EuroIntervention; 2011 May; 7 Suppl K():K7. PubMed ID: 22027732
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-coated balloons in interventional cardiology.
    Giannini F; Naim C; Costopoulos C; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1379-91. PubMed ID: 24138524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting balloon angioplasty.
    Loll A; Pershad A; Buchbinder M
    Indian Heart J; 2004; 56(4):349-53. PubMed ID: 15586748
    [No Abstract]   [Full Text] [Related]  

  • 5. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice?
    Byrne RA; Kastrati A
    EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTCA with drug-coated balloons is associated with immediate decrease of coronary flow reserve.
    Young M; Cuculi F; Erne P
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):682-6. PubMed ID: 23361864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From bench to bedside: initial experience with the Primus drug-coated balloon catheter.
    Briguori C; Virmani R; Kolodgie F; Byrne RA; Steigerwald K; Orlowski M; Joner M
    Minerva Cardioangiol; 2012 Oct; 60(5):507-15. PubMed ID: 23018430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons.
    Abergel E; Beyar R; Roguin A
    Cardiovasc Revasc Med; 2013; 14(2):106-8. PubMed ID: 23195308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadvertent detachment of an entrapped Cutting Balloon from the balloon catheter during treatment of in-stent restenosis.
    Blackman D; Dzavik V
    J Invasive Cardiol; 2005 Nov; 17(11):E27-9. PubMed ID: 16264212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting balloons: future potential indications and applications.
    Choo GH
    EuroIntervention; 2011 May; 7 Suppl K():K112-8. PubMed ID: 22027720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCI in small vessels: the case for a drug-coated balloon based intervention.
    Zeymer U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel coated balloons, the time for awareness has come.
    Cortese B; Sgueglia GA; Granada JF
    Int J Cardiol; 2013 Mar; 164(1):1-2. PubMed ID: 22658568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral applications of drug-coated balloons: past, present and future.
    Krokidis M; Spiliopoulos S; Katsanos K; Sabharwal T
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):281-91. PubMed ID: 22915325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry.
    Vaquerizo B; Serra A; Miranda-Guardiola F; Martínez V; Antoni Gómez-Hospital J; Iñiguez A; Fernández E; Ramón Rumoroso J; Bosa F; Otaegui I
    J Interv Cardiol; 2011 Dec; 24(6):518-28. PubMed ID: 21917013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting balloon: the comeback kid?
    Waksman R; Pakala R
    Circ Cardiovasc Interv; 2009 Aug; 2(4):352-8. PubMed ID: 20031739
    [No Abstract]   [Full Text] [Related]  

  • 18. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
    Bonaventura K; Sonntag S; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the end of restenosis the beginning of a new era?
    Moses JW
    Ital Heart J; 2004 Feb; 5(2):81-4. PubMed ID: 15086136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.